Correction: B cell-extrinsic and intrinsic factors linked to early immune repletion after anti-CD20 therapy in patients with multiple sclerosis of African ancestry
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1649409/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849731894598434816 |
|---|---|
| author | Gregg J. Silverman Abhimanyu N. Amarnani Arnaldo A. Arbini Angie Kim Hannah Kopinsky David Fenyo Ilya Kister |
| author_facet | Gregg J. Silverman Abhimanyu N. Amarnani Arnaldo A. Arbini Angie Kim Hannah Kopinsky David Fenyo Ilya Kister |
| author_sort | Gregg J. Silverman |
| collection | DOAJ |
| format | Article |
| id | doaj-art-d92cc52221a149258a2d2fc535ea228d |
| institution | DOAJ |
| issn | 1664-3224 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Immunology |
| spelling | doaj-art-d92cc52221a149258a2d2fc535ea228d2025-08-20T03:08:24ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-07-011610.3389/fimmu.2025.16494091649409Correction: B cell-extrinsic and intrinsic factors linked to early immune repletion after anti-CD20 therapy in patients with multiple sclerosis of African ancestryGregg J. Silverman0Abhimanyu N. Amarnani1Arnaldo A. Arbini2Angie Kim3Hannah Kopinsky4David Fenyo5Ilya Kister6Department of Medicine, Division of Rheumatology, NYU Grossman School of Medicine, New York, NY, United StatesDepartment of Medicine, Division of Rheumatology, NYU Grossman School of Medicine, New York, NY, United StatesDepartment of Pathology, NYU Grossman School of Medicine, New York, NY, United StatesDepartment of Neurology, NYU Grossman School of Medicine, New York, NY, United StatesDepartment of Neurology, NYU Grossman School of Medicine, New York, NY, United StatesDepartment of Biochemistry and Molecular Pharmacology, NYU Grossman School of Medicine, New York, NY, United StatesDepartment of Neurology, NYU Grossman School of Medicine, New York, NY, United Stateshttps://www.frontiersin.org/articles/10.3389/fimmu.2025.1649409/fullOcrelizumabmultiple sclerosisrituximabCD20African ancestryB-cell repletion |
| spellingShingle | Gregg J. Silverman Abhimanyu N. Amarnani Arnaldo A. Arbini Angie Kim Hannah Kopinsky David Fenyo Ilya Kister Correction: B cell-extrinsic and intrinsic factors linked to early immune repletion after anti-CD20 therapy in patients with multiple sclerosis of African ancestry Frontiers in Immunology Ocrelizumab multiple sclerosis rituximab CD20 African ancestry B-cell repletion |
| title | Correction: B cell-extrinsic and intrinsic factors linked to early immune repletion after anti-CD20 therapy in patients with multiple sclerosis of African ancestry |
| title_full | Correction: B cell-extrinsic and intrinsic factors linked to early immune repletion after anti-CD20 therapy in patients with multiple sclerosis of African ancestry |
| title_fullStr | Correction: B cell-extrinsic and intrinsic factors linked to early immune repletion after anti-CD20 therapy in patients with multiple sclerosis of African ancestry |
| title_full_unstemmed | Correction: B cell-extrinsic and intrinsic factors linked to early immune repletion after anti-CD20 therapy in patients with multiple sclerosis of African ancestry |
| title_short | Correction: B cell-extrinsic and intrinsic factors linked to early immune repletion after anti-CD20 therapy in patients with multiple sclerosis of African ancestry |
| title_sort | correction b cell extrinsic and intrinsic factors linked to early immune repletion after anti cd20 therapy in patients with multiple sclerosis of african ancestry |
| topic | Ocrelizumab multiple sclerosis rituximab CD20 African ancestry B-cell repletion |
| url | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1649409/full |
| work_keys_str_mv | AT greggjsilverman correctionbcellextrinsicandintrinsicfactorslinkedtoearlyimmunerepletionafteranticd20therapyinpatientswithmultiplesclerosisofafricanancestry AT abhimanyunamarnani correctionbcellextrinsicandintrinsicfactorslinkedtoearlyimmunerepletionafteranticd20therapyinpatientswithmultiplesclerosisofafricanancestry AT arnaldoaarbini correctionbcellextrinsicandintrinsicfactorslinkedtoearlyimmunerepletionafteranticd20therapyinpatientswithmultiplesclerosisofafricanancestry AT angiekim correctionbcellextrinsicandintrinsicfactorslinkedtoearlyimmunerepletionafteranticd20therapyinpatientswithmultiplesclerosisofafricanancestry AT hannahkopinsky correctionbcellextrinsicandintrinsicfactorslinkedtoearlyimmunerepletionafteranticd20therapyinpatientswithmultiplesclerosisofafricanancestry AT davidfenyo correctionbcellextrinsicandintrinsicfactorslinkedtoearlyimmunerepletionafteranticd20therapyinpatientswithmultiplesclerosisofafricanancestry AT ilyakister correctionbcellextrinsicandintrinsicfactorslinkedtoearlyimmunerepletionafteranticd20therapyinpatientswithmultiplesclerosisofafricanancestry |